tiprankstipranks
Trending News
More News >
Good Fellow Healthcare Holdings Limited (HK:8143)
:8143
Hong Kong Market
Advertisement

Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

Compare
0 Followers

Top Page

HK:8143

Good Fellow Healthcare Holdings Limited

(8143)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 4o)
Rating:51Neutral
Price Target:
HK$0.00
▼(-100.00% Downside)
The overall stock score is primarily impacted by the company's weak financial performance, characterized by declining revenues, negative equity, and high leverage. While technical analysis indicates some positive momentum, the negative P/E ratio and lack of dividend yield detract from the stock's attractiveness.

Good Fellow Healthcare Holdings Limited (8143) vs. iShares MSCI Hong Kong ETF (EWH)

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company DescriptionGood Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.
How the Company Makes MoneyGood Fellow Healthcare Holdings Limited generates revenue through multiple streams, including the sale of medical equipment and supplies to healthcare institutions and professionals. The company also earns income from healthcare management services, which involve consulting and operational support for healthcare facilities. Additionally, revenue is derived from wellness programs designed to promote health and prevent illness among consumers. Strategic partnerships with healthcare providers and suppliers further enhance the company's market reach and contribute to its earnings, allowing it to leverage synergies and expand its service offerings.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary
The company is facing significant financial challenges, with declining revenues and persistent losses. The balance sheet shows negative equity and high leverage, while cash flow generation is weak with negative free cash flow growth.
Income Statement
30
Negative
The company has experienced a significant decline in revenue, with a revenue growth rate of -30.73% in the most recent year. Gross profit margin is relatively stable at 51.92%, but the net profit margin is deeply negative at -62.82%, indicating substantial losses. EBIT and EBITDA margins are also negative, reflecting operational challenges.
Balance Sheet
20
Very Negative
The balance sheet shows a concerning negative stockholders' equity, leading to a negative debt-to-equity ratio of -1.62. Return on equity is alarmingly high at 155.58%, driven by negative equity, indicating financial instability. The equity ratio is negative, suggesting the company is heavily reliant on debt financing.
Cash Flow
40
Negative
The company has managed to generate positive operating cash flow, but free cash flow growth is negative at -116.36%. The operating cash flow to net income ratio is low at 0.16, and free cash flow to net income ratio is close to 1, indicating limited cash flow generation relative to net losses.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue23.27M16.12M38.96M55.35M54.24M53.89M
Gross Profit7.46M8.37M18.67M27.01M26.66M26.45M
EBITDA-4.41M1.86M-10.12M1.83M4.38M-23.55M
Net Income-2.35M-10.13M-17.11M-5.88M-12.69M-30.18M
Balance Sheet
Total Assets24.67M9.83M29.15M41.70M60.45M191.38M
Cash, Cash Equivalents and Short-Term Investments1.92M4.14M3.88M18.36M25.15M44.89M
Total Debt10.84M10.53M12.23M4.49M7.36M29.73M
Total Liabilities16.00M16.59M27.74M22.32M34.08M158.48M
Stockholders Equity11.69M-6.51M4.36M22.19M29.59M40.23M
Cash Flow
Free Cash Flow-15.78M2.58M-15.35M-3.84M-24.51M-21.21M
Operating Cash Flow-1.29M2.62M-854.00K-1.32M-22.93M1.25M
Investing Cash Flow-1.68M-1.57M-14.46M5.74M2.19M-24.28M
Financing Cash Flow2.39M1.06M4.36M-2.75M-5.61M4.83M

Good Fellow Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.17
Price Trends
50DMA
0.14
Positive
100DMA
0.13
Positive
200DMA
0.09
Positive
Market Momentum
MACD
0.01
Positive
RSI
49.43
Neutral
STOCH
7.98
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Positive. The current price of 0.17 is above the 20-day moving average (MA) of 0.17, above the 50-day MA of 0.14, and above the 200-day MA of 0.09, indicating a neutral trend. The MACD of 0.01 indicates Positive momentum. The RSI at 49.43 is Neutral, neither overbought nor oversold. The STOCH value of 7.98 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
221.35M9.260.00%4.55%-22.12%-28.95%
60
Neutral
95.47M-12.970.00%-11.68%-71.01%
56
Neutral
23.71M2.9469.48%-8.48%0.00%
51
Neutral
HK$192.77M-18.22%-58.63%40.85%
47
Neutral
56.73M-16.82-80.50%-8.20%-10.39%
41
Neutral
10.32M-0.3517.98%14.64%-81.95%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8143
Good Fellow Healthcare Holdings Limited
0.16
0.08
100.00%
HK:2293
Bamboos Health Care Holdings Ltd
0.55
-0.06
-9.84%
HK:8161
MediNet Group Ltd.
0.57
0.27
90.00%
HK:8307
Medicskin Holdings Ltd.
0.14
-0.04
-22.22%
HK:8357
Republic Healthcare Limited
0.15
0.08
114.29%
HK:8437
RMH Holdings Limited
0.16
-0.18
-52.94%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 18, 2025